⌘K

Login Start Free

Home/Filings/4/0001209191-21-046205

4//SEC Filing

GUETH ANTON 4

Accession 0001209191-21-046205

CIK 0001016169other

View on SEC.gov Company Profile

Filed

Jul 8, 8:00 PM ET

Accepted

Jul 9, 5:08 PM ET

Size

4.8 KB

Accession

0001209191-21-046205

Insider Transaction Report

Form 4

Period: 2021-07-08

ANTARES PHARMA, INC.ATRS

Director

Transactions

Sale
Common Stock
2021-07-08$4.29/sh−100,000$429,000→ 467,577 total

Footnotes (1)

[F1]The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ANTARES PHARMA, INC.

CIK 0001016169

Entity typeother

Related Parties

1

filerCIK 0001274940

Filing Metadata

Form type: 4
Filed: Jul 8, 8:00 PM ET
Accepted: Jul 9, 5:08 PM ET
Size: 4.8 KB

View on SEC.gov